PMID: 6408619May 1, 1983Paper

Efficacy of inhaled tobramycin in the treatment of pulmonary exacerbations in children with cystic fibrosis

Pediatric Infectious Disease
D StephensR Gold

Abstract

Two forms of treatment of acute pulmonary exacerbations in patients with cystic fibrosis were compared: intravenous ticarcillin (300 mg drug per kg per day) and tobramycin (10 mg drug per kg per day) versus the same intravenous antibiotic therapy plus inhaled tobramycin (80 mg three times per day). The 16 patients in the intravenous plus inhaled tobramycin group were similar to the 12 control patients in age, sex, Schwachman scores, pulmonary function and pretreatment colony counts of Pseudomonas aeruginosa in sputum. Treatment resulted in significant improvement in clinical status and pulmonary function without any apparent differences in the two groups. However, intravenous plus inhaled tobramycin resulted in temporary eradication of P. aeruginosa in 63% of the patients compared to 25% in the intravenous only group (P = 0.03). Suppression of P. aeruginosa in sputum cultures did not correlate with clinical response to treatment. No renal toxicity or elevations of serum tobramycin were observed in the intravenous plus inhaled tobramycin group.

Citations

Dec 1, 1987·European Journal of Epidemiology·O C TablanW R Jarvis
May 1, 1986·The Journal of Pediatrics·D A Goldmann, J D Klinger
Jun 1, 1993·Archives of Disease in Childhood·J M LittlewoodH Cunliffe
Mar 23, 1999·Archives of Disease in Childhood·S P Conway
Mar 23, 1999·Archives of Disease in Childhood·M Sood, I W Booth
Apr 1, 1997·Thorax·A K Webb, M E Dodd
Mar 11, 2000·Pharmacotherapy·G C Wood, B A Boucher
Mar 20, 2002·Pharmacotherapy·Robert J Kuhn
Sep 13, 2002·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Friedrich C Luft
Nov 13, 2015·Expert Review of Anti-infective Therapy·E Vazquez-EspinosaJ Ancochea
Jun 23, 2009·Expert Opinion on Drug Safety·Amar SafdarBurton F Dickey
Jul 30, 2009·Expert Opinion on Drug Delivery·Daniela Traini, Paul M Young
Sep 24, 1999·Chest·P W Campbell, L Saiman
Feb 28, 2002·Pediatric Annals·Daniel J Weiner
May 27, 2010·Pharmacotherapy·Jennifer LeUNKNOWN Society of Infectious Diseases Pharmacists Aerosolized Antimicrobials Task Force
Mar 1, 1986·The Journal of Pediatrics·M I Marks
Aug 3, 2006·The Veterinary Clinics of North America. Equine Practice·Valerie A Brown, Pamela A Wilkins
May 1, 1986·The Journal of Pediatrics·I MacLuskyF J McLaughlin
Nov 11, 2005·Chronic Respiratory Disease·S P Conway
Jan 15, 1998·Critical Care Medicine·G S Itokazu, R A Weinstein
Dec 11, 2013·Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine·John LamMichael D Parkins
Dec 14, 2012·The Cochrane Database of Systematic Reviews·Gerard RyanTracey Remmington
Aug 1, 2015·The Cochrane Database of Systematic Reviews·Matthew N HurleyPatrick Flume
Aug 10, 2001·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·F FaurissonP Jelazko
Oct 16, 2004·Expert Review of Anti-infective Therapy·Sarah Elkin, Duncan Geddes
Jan 1, 1995·Pediatric Pulmonology. Supplement·A L Smith, B Ramsey
Feb 1, 1991·Journal of Paediatrics and Child Health·P D Sly, P N Le Souëf
Feb 21, 2004·American Journal of Veterinary Research·Harold C McKenzie, Michael J Murray
Jun 27, 2002·Paediatric Drugs·Isabelle Sermet-GaudelusGérard Lenoir
Apr 22, 2015·The Open Respiratory Medicine Journal·Montserrat VendrellJavier de Gracia
Jun 27, 2009·Journal of Medical Microbiology·Geraint B RogersKenneth D Bruce
Oct 31, 2018·The Cochrane Database of Systematic Reviews·Sherie SmithEdward Charbek
Sep 4, 2015·Pediatric Pulmonology·Lindsay J CaverlyJohn J LiPuma
Apr 1, 1987·Drug Intelligence & Clinical Pharmacy·S A Stout, H Derendorf

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.